Rational Pharmacotherapy in Cardiology

Advanced search


Full Text:


Arrhythmias are one of the most complex, insufficiently studied, and therefore one of the most urgent problems of modern cardiology. A wide spectrum of clinical manifestations of cardiac rhythm disorders (CRDs), their detection both in various diseases and in healthy people, necessitate the study of their prevalence in populations. In the majority of conducted epidemiological studies a single recording of electrocardiogram (ECG) was used. This is the most usable method for examination of large populations but a little informative for detecting arrhythmias. The small frequency of CRDs detected during ECG recording is due to the short duration of its registration. An increase in the duration of ECG recording (ECG recording for 2 minutes, continuous recording of 100 cardiocycles) leads to an increase in arrhythmias frequency. With a wide introduction in the practice of ECG monitoring by Holter as well as the use of individual recorders of electrocardiogram ("handheld ECG recording") data appeared indicating a much higher frequency of CRDs. Data obtained in numerous studies on the prevalence of arrhythmias are very contradictory and depend both on the characteristics of populations and on methodological approaches, which requires further epidemiological studies. At the same time, the main initiating point of such researches is the clinical significance of certain CRDs. However, if the clinical significance of ventricular tachyarrhythmias and atrial fibrillation does not currently cause any doubt, the clinical significance of extrasystoles is highly controversial, despite the high their prevalence, including this in prognostically unfavorable groups of patients. In recent years, the results of a number of studies have been published that allow to think about the adverse effects of both supraventricular and ventricular extrasystoles of the course of certain cardiovascular diseases. Very heterogeneous results of the performed studies, as well as data about the high clinical significance of individual CRDs, make further epidemiological studies in this field extremely urgent.

About the Authors

E. V. Zatonskaya
Krasnoyarsk State Medical University named after Prof. V.F. Voyno-Yasenetsky
Russian Federation

Elena V. Zatonskaya - MD, Post-Graduate Student, Chair of Cardiology and Functional Diagnostics, Institute of Professional Education 

Partizana Zheleznyaka ul. 1, Krasnoyarsk, 660022

G. V. Matyushin
Krasnoyarsk State Medical University named after Prof. V.F. Voyno-Yasenetsky
Russian Federation

Gennady V. Matyushin - MD, PhD, Professor, Head of Chair of Cardiology and Functional Diagnostics, Institute of Professional Education 

Partizana Zheleznyaka ul. 1, Krasnoyarsk, 660022

N. G. Gogolashvili
Krasnoyarsk State Medical University named after Prof. V.F. Voyno-Yasenetsky; Research Institute of Medical Problems of the North
Russian Federation

Nikolay G. Gogolashvili - MD, PhD, Professor, Chair of Cardiology and Functional Diagnostics, Institute of Professional Education, Krasnoyarsk State Medical University named after Prof. V.F. Voyno-Yasenetsky; Head of Cardiology Department, Research Institute of Medical Problems of the North 

Partizana Zheleznyaka ul. 3g, Krasnoyarsk, 660022


1. Gorenek B., Blomstrom Lundqvist C., Brugada Terradellas J., et al. Cardiac arrhythmias in acute coronary syndromes: position paper from the joint EHRA, ACCA, and EAPCI task force. Europace. 2014;16:1655-73.

2. Rahimi K., Watzlawek S., Thiele H., et al. Incidence, time course, and predictors of early malignant ventricular arrhythmias after non-ST-segment elevation myocardial infarction in patients with early invasive treatment. Eur Heart J. 2006;27:1706-11.

3. Gogolashvili N.G., Litvinenko M.V., Pochikaeva T.N., et al. Ventricular arrhythmia prevalence and treatment with omega-3 polyunsaturated fatty acids in patients who suffered myocardial infarction within the last year. Kardiovaskulyarnaya Terapiya i Profilaktika. 2011;10(5):57-62. (In Russ.) [Гоголашвили Н.Г., Литвиненко М.В., Почикаева Т.Н. и др. Частота желудочковых аритмий и возможности их лечения препаратом омега-3 полиненасыщенных жирных кислот у больных в течение года после инфаркта миокарда. Кардиоваскулярная Терапия и Профилактика. 2011;10(5):57-62].

4. Gogolashvili N.G., Litvinenko M.V., Pochikaeva T.N. et al. Possibilities of apreparation omega-3 polyunsaturated fatty acids in the treatment of patients with ventricular arrhythmias and myocardial infarction. Kardiologiia. 2011;51(8):28-31. (In Russ.) [Гоголашвили Н.Г., Литвиненко М.В., Почикаева Т.Н. и др. Возможности препарата омега-3 полиненасыщенных жирных кислот в лечении больных с желудочковыми нарушениями ритма и инфарктом миокарда в анамнезе. Кардиология. 2011;51(8):28-31].

5. Parmon E.V., Treshkur T.V., Shlyakhto E.V. Idiopathic ventricular arrhythmias (problem analysis). Vestnik Aritmologii. 2003;31:60-71. (In Russ.) [Пармон Е.В., Трешкур Т.В., Шляхто Е.В. Идиопатические желудочковые нарушения ритма (анализ проблемы). Вестник Аритмологии. 2003;31: 60-71].

6. Hwang J.K., Park S.J., On Y.K., et al. Clinical characteristics and features of frequent idiopathic ventricular premature complexes in the Korean population. Korean Circ J. 2015;45(5):391-7.

7. Cheriyath P., He F., Peters I., et al. Relation of atrial and/or ventricular premature complexes on a two-minute rhythm strip to the risk of sudden cardiac death (the atherosclerosis risk in communities [ARIC] study). Am J Cardiol. 2011;107(2):151-5.

8. Ephrem G., Levine M., Friedmann P., Schweitzer P. The prognostic significance of frequency and morphology of premature ventricular complexes during ambulatory holter monitoring. Ann Noninvasive Electrocardiol. 2013;18(2):118-25.

9. Agarwal S.K., Simpson R.J. Jr., Rautaharju P., et al. Relation of ventricular premature complexes to heart failure (from the Atherosclerosis Risk In Communities [ARIC] Study). Am J Cardiol. 2012;109(1): 105-9.

10. Piccini J.P., White J.A., Mehta R.H., et al. Sustained ventricular tachycardia and ventricular fibrillation complicating non-ST-segment-elevation acute coronary syndromes. Circulation. 2012;126(1): 41-9.

11. Mamchur S.E., Ardashev A.V. Sudden cardiac death and Wolff-Parkinson-White syndrome. Vestnik Aritmologii. 2014;76:30-6. (In Russ.) [Мамчур С.Е., Ардашев А.В. Внезапная сердечная смерть и синдром Вольфа-Паркинсона-Уайта. Вестник Аритмологии. 2014;76:30-6].

12. Dukes J.W., Dewland T.A., Vittinghoff E., et al. Ventricular ectopy as a predictor of heart failure and death. J Am Coll Cardiol. 2015;66(2):101-9.

13. Murakoshi N., Aonuma K. Epidemiology of arrhythmias and sudden cardiac death in Asia. Circ J. 2013;77:2419-31.

14. Hingorani P., Karnad D.R., Natekar M., et al. Baseline and new-onset morphologic ECG abnormalities in healthy volunteers in phase I studies receiving placebo: changes over a 6-week follow-up period. J Clin Pharmacol. 2014;54(7):776-84.

15. Chiang B.N., Perlman L.V., Fulton М. Predisposing factors in sudden cardiac death in Techumsem (Michigan): A prospective study. Circulation. l970;41(1):31-4.

16. De Bacquer D., De Backer G., Kornitzer M. Prevalence of ECG findings in large population based samples of men and women. Heart. 2000;84(6):625-33.

17. Klich A., Kocemba J., Potocka-Plazak К. Rhythm and conduction disorders among the adult population. Epidemiologic data. Przegl Lek. 1994;51(2):104-6.

18. Gupta R., Sharma S. Prevalence of asymptomatic electrocardiographic abnormalities in a rural population. J Assoc Physicians India. 1996;44(11):775-7.

19. Hirose H., Ishikawa S., Gotoh T., et al. Cardiac mortality of premature ventricular complexes in healthy people in Japan. J Cardiol. 2010;56(1):23-6.

20. Lok N.S., Lau C.P. Prevalence of palpitations, cardiac arrhythmias and their associated risk factors in ambulant elderly. Int J Cardiol. 1996;54(3):231-6.

21. Kiatchoosakun S., Pachirat O., Chirawatkul А., et al. Prevalence of cardiac arrhythmias in Thai community. J Med Assoc Thai. 1999;82(7):727-33.

22. Klich-Raczka A., Zyczkowska J., Grodzicki T. Electrocardiogram in centenarians. Kardiol Pol. 2003;58(4):275-81.

23. Molander U., Dey D.K., Sundh V., Steen В. ECG abnormalities in the elderly: prevalence, time and generation trends and association with mortality. Aging Clin Exp Res. 2003;15(6):488-93.

24. Gogolashvili N.G., Novgorodtseva N.Ia., Polikarpov L.S. The frequency of heart rhythm disturbances in rural native population of Yakutia. Sibirskij Medicinskij Zurnal. 2004;2:79-82. (In Russ.). [Гоголашвили Н.Г., Новгородцева Н.Я., Поликарпов Л.С. Частота аритмий сердца в популяции коренного сельского населения Якутии. Сибирский Медицинский Журнал. 2004; 2: 79-82].

25. Gogolashvili N.G., Novgorodtseva N.Ia., Polikarpov L.S., Karpov R.S. Incidence of heart rate disorders in rural population of Krasnoiarsk region. Ter Arkhiv. 2004;76(1):41-4. (In Russ.). [Гоголашвили Н.Г., Новгородцева Н.Я., Поликарпов Л.С., Карпов Р.С. Частота аритмий сердца в популяции сельского населения Красноярского края. Терапевтический Архив. 2004; 76(1):41-4].

26. Simpson R.J. Jr., Cascio W.E., Schreiner P.J., et al. Prevalence of premature ventricular contractions in a population of African American and white men and women: the Atherosclerosis Risk in Communities (ARIC) study. Am Heart J. 2002;143(3):535-40.

27. Kamel H., Elkind M.S., Bhave P.D., et al. Paroxysmal supraventricular tachycardia and the risk of ischemic stroke. Stroke. 2013;44(6):1550-4.

28. Orejarena L.A., Vidaillet H.Jr., DeStefano F., et al. Paroxysmal supraventricular tachycardia in the general population. J Am Coll Cardiol. 1998;31(1):150-7.

29. Baratta L., Maffeo N., Tubani L., et al. Arrhythmias in the aged: prevalence and correlation with symptoms. Recenti Prog Med. 1996;87(3):96-101.

30. Paparella N., Alboni P. Classification and prevalence of supraventricular tachyarrhythmia. Cardiologia 1991;36(8):7-10.

31. Manolio T.A., Furberg C.D., Rautaharju Р.М., et al. Cardiac arrhythmias on 24-h ambulatory electrocardiography in older women and men: the Cardiovascular Health Study. J Am Coll Cardiol. 1994;23(4):916-25.

32. Hingorani P., Karnad D.R., Rohekar P., et al. Arrhythmias seen in baseline 2-hour Holter ECG recordings in healthy normal volunteers during phase 1 clinical trials. J Clin Pharmacol. 2016;56(7): 885-93.

33. Wolf P.A., Abbott R.D., Kannel W.B. Atrial fibrillation as an independent risk factor for stroke: the Fram-ingham Study. Stroke. 1991;22(8):983-8.

34. Benjamin E.J., Wolf P.A., D’Agostino R.B., et al. Impact of atrial fibrillation on the risk of death: the Fram-ingham Heart Study. Circulation. 1998;98(10):946-52.

35. Kannel W.B., Abbott R.D., Savage D.D., McNamara P.M. Epidemiologic features of chronic atrial fibrillation: the Framingham study. N Engl J Med. 1982;306(17):1018-22.

36. Go A.S., Hylek E.M., Phillips K.A., et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA. 2001;285(18):2370-5.

37. Murphy N.F., Simpson C.R., Jhund P.S., et al. A national survey of the prevalence, incidence, primary care burden and treatment of atrial fibrillation in Scotland. Heart. 2007;93(5):606-12.

38. Wilke T., Groth A., Mueller S., et al. Incidence and prevalence of atrial fibrillation: an analysis based on 8.3 million patients. Europace. 2013;15(4):486-93.

39. Claes N., Van Laethem C., Goethals M., et al. Prevalence of atrial fibrillation in adults participating in a large-scale voluntary screening programme in Belgium. Acta Cardiol. 2012;67(3): 273-8.

40. Schnabel R.B., Wilde S., Wild P.S., et al. Atrial fibrillation: its prevalence and risk factor profile in the German general population. Dtsch Arztebl Int. 2012;109(16):293-9.

41. Meschia J.F., Merrill P., Soliman E.Z., et al. Racial disparities in awareness and treatment of atrial fibrillation: the REasons for Geographic and Racial Differences in Stroke (REGARDS) Study. Stroke. 2010;41(4):581-7.

42. Mandalenakis Z., Von Koch L., Eriksson H., et al. The risk of atrial fibrillation in the general male population: a lifetime follow-up of 50-year-old men. Europace. 2015;17(7):1018-22.

43. Schnabel R.B., Johannsen S.S., Wild P.S., Blankenberg S. Prevalence and risk factors of atrial fibrillation in Germany: data from the Gutenberg Health Study. Herz. 2015;40(1):8-15.

44. Iwahana H., Ishikawa S., Ishikawa J., et al. Atrial fibrillation is a major risk factor for stroke, especially in women: the Jichi Medical School cohort study. J Epidemiol. 2011;21(2):95-101.

45. Li Y., Wu Y.F., Chen K.P., et al. Prevalence of atrial fibrillation in China and its risk factors. Biomed Environ Sci. 2013;26(9):709-16.

46. Svennberg E., Engdahl J., Al-Khalili F., et al. Mass screening for untreated atrial fibrillation: The STROKE-STOP Study. Circulation. 2015;131(25):2176-84.

47. Engdahl J., Andersson L., Mirskaya M., Rosenqvist M. Stepwise screening of atrial fibrillation in a 75-year old population: implications for stroke prevention. Circulation. 2013;127(8):930-7.

48. Hendrikx T., Hornsten R., Rosenqvist M., Sandstrom H. Screening for atrial fibrillation with baseline and intermittent ECG recording in an out-of-hospital population. BMC Cardiovasc Disord. 2013;13:41.

49. Inohara T., Kohsaka S., Okamura T., et al. Long-term outcome of healthy participants with atrial premature complex: a 15-year follow-up of the NIPPON DATA 90 cohort. PLoS One. 2013;8(11):e80853.

50. Murakoshi N., Xu D., Sairenchi T., et al. Prognostic impact of supraventricular premature complexes in community-based health checkups: the Ibaraki Prefectural Health Study. Eur Heart J. 2015;36(3): 170-8.

51. Qureshi W., Shah A.J., Salahuddin T., Soliman E.Z. Long-term mortality risk in individuals with atrial or ventricular premature complexes (results from the Third National Health and Nutrition Examination Survey). Am J Cardiol. 2014;114(1):59-64.

52. Larsen B.S., Kumarathurai P., Falkenberg J., et al. Excessive atrial ectopy and short atrial runs increase the risk of stroke beyond incident atrial fibrillation. J Am Coll Cardiol. 2015;66(3):232-41.

53. Agarwal S.K., Chao J., Peace F., et al. Premature ventricular complexes on screening electrocardiogram and risk of ischemic stroke. Stroke. 2015;46(5):1365-7.

54. Lee V., Hemingway H., Harb R., et al. The prognostic significance of premature ventricular complexes in adults without clinically apparent heart disease: a meta-analysis and systematic review. Heart. 2012;98(17):1290-8.

55. Ataklte F., Erqou S., Laukkanen J., Kaptoge S. Meta-analysis of ventricular premature complexes and their relation to cardiac mortality in general populations. Am J Cardiol. 2013;112(8):1263-70.


For citations:

Zatonskaya E.V., Matyushin G.V., Gogolashvili N.G. THE PREVALENCE AND CLINICAL SIGNIFICANCE OF CARDIAC ARRHYTHMIAS. Rational Pharmacotherapy in Cardiology. 2017;13(3):403-408. (In Russ.)

Views: 2541

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.

ISSN 1819-6446 (Print)
ISSN 2225-3653 (Online)